Paper42333641
Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.
Adams C and 19 others. J Am Heart Assoc, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial. Papers, record 42333641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42333641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neuroprotective Agents | Major topic |
| Ischemic Stroke | Major topic |
| Stroke | Major topic |
| Humans | |
| Double-Blind Method | |
| Female | |
| Male | |
| Time Factors | |
| Aged | |
| Treatment Outcome | |
| Middle Aged | |
| Peptide Fragments |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42622147 | Correction to: Safety and Efficacy of Nerinetide at Year in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial. | https://conductscience.org/library/papers/42622147 |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34774198 | Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis. | Lancet | 2022 | https://conductscience.org/library/papers/34774198 | PubMed |
| 2 | 12399596 | Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. | Science | 2002 | https://conductscience.org/library/papers/12399596 | PubMed |
| 3 | 41583582 | Nerinetide Reduces Early Infarct Growth Among Stroke Patients Undergoing EVT Without Intravenous Alteplase. | Stroke Vasc Interv Neurol | 2024 | https://conductscience.org/library/papers/41583582 | PubMed |
| 4 | 2749846 | Measurements of acute cerebral infarction: a clinical examination scale. | Stroke | 1989 | https://conductscience.org/library/papers/2749846 | PubMed |
| 5 | 23390923 | Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23390923 | PubMed |
| 6 | 22388811 | Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. | Nature | 2012 | https://conductscience.org/library/papers/22388811 | PubMed |
| 7 | 32087818 | Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. | Lancet | 2020 | https://conductscience.org/library/papers/32087818 | PubMed |
| 8 | 18617669 | Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. | Stroke | 2008 | https://conductscience.org/library/papers/18617669 | PubMed |
| 9 | 29364767 | Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29364767 | PubMed |
| 10 | 33827973 | Plasmin-resistant PSD-95 inhibitors resolve effect-modifying drug-drug interactions between alteplase and nerinetide in acute stroke. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/33827973 | PubMed |
| 11 | 26022639 | Effect Size Estimates for the ESCAPE Trial: Proportional Odds Regression Versus Other Statistical Methods. | Stroke | 2015 | https://conductscience.org/library/papers/26022639 | PubMed |
| 12 | 34841963 | Impact of minimal sufficient balance, minimization, and stratified permuted blocks on bias and power in the estimation of treatment effect in sequential clinical trials with a binary endpoint. | Stat Methods Med Res | 2022 | https://conductscience.org/library/papers/34841963 | PubMed |
| 13 | 23035045 | A translational paradigm for the preclinical evaluation of the stroke neuroprotectant Tat-NR2B9c in gyrencephalic nonhuman primates. | Sci Transl Med | 2012 | https://conductscience.org/library/papers/23035045 | PubMed |
| 14 | 10905241 | Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. | Lancet | 2000 | https://conductscience.org/library/papers/10905241 | PubMed |
| 15 | 39955120 | Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study. | Lancet | 2025 | https://conductscience.org/library/papers/39955120 | PubMed |
| 16 | 24076337 | High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. | Lancet Neurol | 2013 | https://conductscience.org/library/papers/24076337 | PubMed |
| 17 | 34484897 | Variability of the Modified Rankin Scale Score Between Day 90 and 1 Year After Ischemic Stroke. | Neurol Clin Pract | 2021 | https://conductscience.org/library/papers/34484897 | PubMed |
| 18 | 26661213 | Efficacy of the PSD95 inhibitor Tat-NR2B9c in mice requires dose translation between species. | J Cereb Blood Flow Metab | 2016 | https://conductscience.org/library/papers/26661213 | PubMed |
| 19 | 39955119 | Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial. | Lancet | 2025 | https://conductscience.org/library/papers/39955119 | PubMed |
| 20 | 29129157 | Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29129157 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42333641
GET https://conductscience.org/api/papers/v1/42333641/references?page=2